Is Nabla compliant with the EU AI Act?
Short answer: it depends on how you use it. The Act does not certify tools as “compliant”. It classifies each use into a risk tier, and your obligations follow from there.
If used for medical diagnosis or triage, these tools can be high-risk under Annex III and the medical-device rules. Used for admin or note-taking, the risk is usually lower.
What this means for you
If your organisation uses Nabla in the EU, you are a deployer. Inventory the system, write down what you use it for, and classify that use. Then handle the obligations that apply: AI literacy for everyone, transparency for customer-facing use, and the heavier high-risk duties only where an Annex III purpose is involved.
Nablain Veillo’s catalog
Nablaisn’t in our counsel-reviewed catalog yet. That doesn’t leave you stuck: when you add it in Veillo and say how you use it, the rules engine classifies that use right away, an AI-assisted suggestion fills any gap, and anything high-risk routes to a person before it becomes a record. As counsel reviews this tool, the reviewed answer appears here and flows into every account that uses it.
How healthcare tools tend to land
Typical use-case patterns in this category, and the tier each one points to. Your actual tier depends on how you use Nabla.
This page is general information, not a classification of your specific deployment, and not legal advice. Run the free diagnosis to classify your actual use of Nabla.
Classify your use of Nabla, free.
Add Nabla and your other tools, tell us what you use them for, and get a classified register in minutes. No signup.
14-day trial of Business · no card · see pricing